Literature DB >> 1646626

IL-4 and IL-2 upregulate the expression of antigen B7, the B cell counterstructure to T cell CD28: an amplification mechanism for T-B cell interactions.

A Vallé1, J P Aubry, I Durand, J Banchereau.   

Abstract

We recently generated mAb 104 which is specific for the B cell activation antigen Ag B7. With this we studied the regulation of Ag B7 expression on normal tonsillar B lymphocytes as well as the activities of B7+ and B7- activated B cells. SAC and to a lesser extent anti-IgM antibody upregulated Ag B7 and this was further enhanced by IL-2 and most notably IL-4. Ag B7 was expressed on virtually all sIgG+ and sIgA+ B cells and approximately half of the sIgD+ and sIgM+ B cells. SAC-stimulated B7+ B cells proliferated and produced IgM, IgG and IgA in response to IL-2 and IgM and IgG in response to IL-4. SAC-stimulated B7- B cells proliferated and produced only IgM in response to IL-2 and IL-4. Considering that Ag B7 has recently been shown to be the counterstructure of the T cell CD28 and that CD28 triggering strongly enhances cytokine production by T cells, it is likely that the CD28/B7 interaction represents an important amplification phenomenon in T-B cell interaction leading to humoral immune responses. The preferential expression of Ag B7 on IgG and IgA committed cells suggests that CD28/B7 interaction may be more specific to secondary antibody responses provided by memory T and B cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1646626     DOI: 10.1093/intimm/3.3.229

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  10 in total

1.  Differential expression of costimulatory molecules in chronic inflammatory periodontal disease tissue.

Authors:  K Orima; K Yamazaki; T Aoyagi; K Hara
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

Review 2.  B effector cells in rheumatoid arthritis and experimental arthritis.

Authors:  Alison Finnegan; Susan Ashaye; Keith M Hamel
Journal:  Autoimmunity       Date:  2012-04-19       Impact factor: 2.815

Review 3.  Antigen-presenting cell engineering. The molecular toolbox.

Authors:  M L Tykocinski; D R Kaplan; M E Medof
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

Review 4.  CD28/CTLA-4 and CD80/CD86 families: signaling and function.

Authors:  J M Slavik; J E Hutchcroft; B E Bierer
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

5.  Costimulation of T-cell activation and virus production by B7 antigen on activated CD4+ T cells from human immunodeficiency virus type 1-infected donors.

Authors:  O K Haffar; M D Smithgall; J Bradshaw; B Brady; N K Damle; P S Linsley
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

6.  Influence of CD28 co-stimulation on cytokine production is mainly regulated via interleukin-2.

Authors:  H M Kuiper; R de Jong; M Brouwer; K Lammers; J Wijdenes; R A van Lier
Journal:  Immunology       Date:  1994-09       Impact factor: 7.397

7.  Targeting co-stimulatory pathways in gene therapy.

Authors:  Xiaopei Huang; Yiping Yang
Journal:  Front Microbiol       Date:  2011-09-28       Impact factor: 5.640

8.  Excessive Costimulation Leads to Dysfunction of Adoptively Transferred T Cells.

Authors:  Dinali Wijewarnasuriya; Christina Bebernitz; Andrea V Lopez; Sarwish Rafiq; Renier J Brentjens
Journal:  Cancer Immunol Res       Date:  2020-03-25       Impact factor: 11.151

9.  B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells.

Authors:  C Caux; B Vanbervliet; C Massacrier; M Azuma; K Okumura; L L Lanier; J Banchereau
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

10.  Functional expression of B7/BB1 on activated T lymphocytes.

Authors:  M Azuma; H Yssel; J H Phillips; H Spits; L L Lanier
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.